Financhill
Sell
20

NIO Quote, Financials, Valuation and Earnings

Last price:
$3.81
Seasonality move :
21.67%
Day range:
$3.57 - $3.85
52-week range:
$3.61 - $7.71
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.84x
P/B ratio:
9.59x
Volume:
79M
Avg. volume:
70.9M
1-year change:
-16.67%
Market cap:
$7.8B
Revenue:
$9.2B
EPS (TTM):
-$1.54
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $2.4B $5.6B $7.3B $7.9B $9.2B
Revenue Growth (YoY) 107.96% 137.57% 31.06% 7.2% 16.51%
 
Cost of Revenues $2.1B $4.5B $6.6B $7.4B $8.3B
Gross Profit $271.5M $1.1B $765.8M $431.4M $904.9M
Gross Profit Margin 11.52% 18.88% 10.44% 5.49% 9.88%
 
R&D Expenses $360.5M $711.2M $1.6B $1.9B $1.8B
Selling, General & Admin $511.1M $973.8M $1.4B $1.7B $2.2B
Other Inc / (Exp) -$62.4M $38.3M $34.7M $55.1M -$84.4M
Operating Expenses $939.1M $1.8B $3.1B $3.6B $4B
Operating Income -$667.7M -$696.4M -$2.3B -$3.2B -$3B
 
Net Interest Expenses $37.5M -- -- -- --
EBT. Incl. Unusual Items -$767.7M -$615.6M -$2.1B -$2.9B -$3.1B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $922.8K $6.5M $8.2M $36.9M -$3.2M
Net Income to Company -$768.6M -$622.1M -$2.1B -$2.9B --
 
Minority Interest in Earnings -$44.4M -$1B -$18.2M -$60.4M -$35.7M
Net Income to Common Excl Extra Items -$813M -$1.6B -$2.2B -$3B -$3.2B
 
Basic EPS (Cont. Ops) -$0.69 -$1.04 -$1.32 -$1.76 -$1.54
Diluted EPS (Cont. Ops) -$0.69 -$1.04 -$1.32 -$1.76 -$1.54
Weighted Average Basic Share $1.2B $1.6B $1.6B $1.7B $2.1B
Weighted Average Diluted Share $1.2B $1.6B $1.6B $1.7B $2.1B
 
EBITDA -$481.9M -$152.6M -$1.5B -$2.1B -$3B
EBIT -$705.9M -$516.9M -$2.1B -$2.8B -$3B
 
Revenue (Reported) $2.4B $5.6B $7.3B $7.9B $9.2B
Operating Income (Reported) -$667.7M -$696.4M -$2.3B -$3.2B -$3B
Operating Income (Adjusted) -$705.9M -$516.9M -$2.1B -$2.8B -$3B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $1B $1.5B $2.3B $2.4B $2.7B
Revenue Growth (YoY) 147.7% 54.46% 45.96% 5.23% 15.25%
 
Cost of Revenues $829.4M $1.3B $2.2B $2.2B $2.4B
Gross Profit $172.2M $265.6M $87.4M $177.7M $320.9M
Gross Profit Margin 17.2% 17.17% 3.87% 7.48% 11.72%
 
R&D Expenses $125.1M $285.7M $559.6M $551.8M $505.3M
Selling, General & Admin $182M $368.5M $412.7M $421.8M $678M
Other Inc / (Exp) -$66.2M $8.1M $99.2M $39.8M -$101.6M
Operating Expenses $312.7M $647.7M $1B $1.1B $1.2B
Operating Income -$140.5M -$382.1M -$946.9M -$920.4M -$838.5M
 
Net Interest Expenses $2.5M -- -- -- $58M
EBT. Incl. Unusual Items -$209.2M -$329.7M -$811M -$713.4M -$998.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $251K $5.2M $2.4M $32.4M -$9.7M
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -$15.6M -$5.6M -$8.6M -$31.3M -$2.8M
Net Income to Common Excl Extra Items -$225M -$340.5M -$821.9M -$777M -$991.2M
 
Basic EPS (Cont. Ops) -$0.16 -$0.21 -$0.50 -$0.44 -$0.48
Diluted EPS (Cont. Ops) -$0.16 -$0.21 -$0.50 -$0.44 -$0.48
Weighted Average Basic Share $1.4B $1.6B $1.6B $1.8B $2.1B
Weighted Average Diluted Share $1.4B $1.6B $1.6B $1.8B $2.1B
 
EBITDA -$129.9M -$198M -$798.3M -$690.6M -$940.1M
EBIT -$195M -$317.9M -$798.3M -$690.6M -$940.1M
 
Revenue (Reported) $1B $1.5B $2.3B $2.4B $2.7B
Operating Income (Reported) -$140.5M -$382.1M -$946.9M -$920.4M -$838.5M
Operating Income (Adjusted) -$195M -$317.9M -$798.3M -$690.6M -$940.1M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $2.4B $5.6B $7.3B $7.8B $9.2B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $2.1B $4.5B $6.5B $7.4B $8.3B
Gross Profit $277M $1.1B $771.1M $424.3M $904.2M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $362.1M $712.5M $1.6B $1.9B $1.8B
Selling, General & Admin $571.4M $1.1B $1.5B $1.7B $2.2B
Other Inc / (Exp) -$65.3M $38.2M $30.8M $54.6M -$84.1M
Operating Expenses $942.6M $1.8B $3.1B $3.6B $4B
Operating Income -$665.6M -$699M -$2.3B -$3.2B -$3B
 
Net Interest Expenses $37.1M -- -- -- --
EBT. Incl. Unusual Items -$768M -$617.7M -$2.1B -$2.9B -$3.1B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $921.7K $6.6M $8.3M $36.4M -$3.1M
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -$44.8M -$1B -$17.9M -$60M -$35.7M
Net Income to Common Excl Extra Items -$813.7M -$1.6B -$2.1B -$3B -$3.2B
 
Basic EPS (Cont. Ops) -$0.70 -$1.04 -$1.32 -$1.76 -$1.54
Diluted EPS (Cont. Ops) -$0.70 -$1.04 -$1.32 -$1.76 -$1.54
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA -$641.3M -$399.4M -$2.1B -$2.8B -$3B
EBIT -$706.4M -$519.3M -$2.1B -$2.8B -$3B
 
Revenue (Reported) $2.4B $5.6B $7.3B $7.8B $9.2B
Operating Income (Reported) -$665.6M -$699M -$2.3B -$3.2B -$3B
Operating Income (Adjusted) -$706.4M -$519.3M -$2.1B -$2.8B -$3B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $5.6B $7.3B $7.8B $9.2B --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $4.5B $6.5B $7.4B $8.3B --
Gross Profit $1.1B $771.1M $424.3M $904.2M --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $712.5M $1.6B $1.9B $1.8B --
Selling, General & Admin $1.1B $1.5B $1.7B $2.2B --
Other Inc / (Exp) $38.2M $30.8M $54.6M -$84.1M --
Operating Expenses $1.8B $3.1B $3.6B $4B --
Operating Income -$699M -$2.3B -$3.2B -$3B --
 
Net Interest Expenses $46.9M -- -- $58M --
EBT. Incl. Unusual Items -$617.7M -$2.1B -$2.9B -$3.1B --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $6.6M $8.3M $36.4M -$3.1M --
Net Income to Company -$289.3M -$686.8M -$1.5B -- --
 
Minority Interest in Earnings -$1B -$17.9M -$60M -$35.7M --
Net Income to Common Excl Extra Items -$1.6B -$2.1B -$3B -$3.2B --
 
Basic EPS (Cont. Ops) -$1.04 -$1.32 -$1.76 -$1.54 --
Diluted EPS (Cont. Ops) -$1.04 -$1.32 -$1.76 -$1.54 --
Weighted Average Basic Share $6.3B $6.5B $6.8B $8.2B --
Weighted Average Diluted Share $6.3B $6.5B $6.8B $8.2B --
 
EBITDA -$399.4M -$2.1B -$2.8B -$3B --
EBIT -$519.3M -$2.1B -$2.8B -$3B --
 
Revenue (Reported) $5.6B $7.3B $7.8B $9.2B --
Operating Income (Reported) -$699M -$2.3B -$3.2B -$3B --
Operating Income (Adjusted) -$519.3M -$2.1B -$2.8B -$3B --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $5.9B $2.4B $2.9B $4.6B $2.6B
Short Term Investments $604.7M $5.8B $2.8B $2.4B $1.9B
Accounts Receivable, Net $172M $438.9M $741.8M $657.1M $229.6M
Inventory $165.5M $322.6M $1.2B $744.5M $970.8M
Prepaid Expenses $19.8M $39.5M $129.2M $115.1M --
Other Current Assets -$6.8M -- -- -- $497.7M
Total Current Assets $7.1B $10B $8.6B $9.9B $8.5B
 
Property Plant And Equipment $988.4M $1.7B $3.4B $5.3B $5.3B
Long-Term Investments $45.9M $480M $921.3M $774.1M $428.2M
Goodwill -- -- -- -- --
Other Intangibles $31.3M $31.2M $30.8M $33.4M $31.7M
Other Long-Term Assets $8.5M $1.8M $19.5M $22.5M $502.8M
Total Assets $8.4B $13B $14B $16.6B $14.7B
 
Accounts Payable $974.7M $2B $1.8B $2B $4.7B
Accrued Expenses $57M $84.5M $243.9M $152.3M $2.2B
Current Portion Of Long-Term Debt $58.2M $324.4M $179.4M $710.8M $1.3B
Current Portion Of Capital Lease Obligations $88.8M $121.2M $153.1M $249.5M $266.6M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $2.1B $4.6B $6.6B $8.2B $8.5B
 
Long-Term Debt $908.9M $1.5B $1.6B $1.8B $1.6B
Capital Leases -- -- -- -- --
Total Liabilities $3.5B $7.5B $10.5B $12.9B $13.9B
 
Common Stock $410.1K $453.7K $423.5K $511K --
Other Common Equity Adj -$10M -$43.3M $150.2M $61.1M --
Common Equity $4.2B $5.4B $3.5B $3.6B $817.4M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $718.4M $11.9M $32.1M $26.7M $13.4M
Total Equity $4.9B $5.5B $3.5B $3.6B $830.7M
 
Total Liabilities and Equity $8.4B $13B $14B $16.6B $14.7B
Cash and Short Terms $6.5B $8.2B $5.7B $7B $4.6B
Total Debt $1.2B $2.7B $4.2B $5.4B $2.8B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $5.9B $2.4B $2.9B $4.6B $2.6B
Short Term Investments $604.7M $5.8B $2.8B $2.4B $1.9B
Accounts Receivable, Net $172M $438.9M $741.8M $657.1M $229.6M
Inventory $165.5M $322.6M $1.2B $744.5M $970.8M
Prepaid Expenses $19.8M $39.5M $129.2M $115.1M --
Other Current Assets -$6.8M -- -- -- $497.7M
Total Current Assets $7.1B $10B $8.6B $9.9B $8.5B
 
Property Plant And Equipment $988.4M $1.7B $3.4B $5.3B $5.3B
Long-Term Investments $45.9M $480M $921.3M $774.1M $428.2M
Goodwill -- -- -- -- --
Other Intangibles $31.3M $31.2M $30.8M $33.4M $31.7M
Other Long-Term Assets $8.5M $1.8M $19.5M $22.5M $502.8M
Total Assets $8.4B $13B $14B $16.6B $14.7B
 
Accounts Payable $974.7M $2B $1.8B $2B $4.7B
Accrued Expenses $57M $84.5M $243.9M $152.3M $2.2B
Current Portion Of Long-Term Debt $58.2M $324.4M $179.4M $710.8M $1.3B
Current Portion Of Capital Lease Obligations $88.8M $121.2M $153.1M $249.5M $266.6M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $2.1B $4.6B $6.6B $8.2B $8.5B
 
Long-Term Debt $908.9M $1.5B $1.6B $1.8B $1.6B
Capital Leases -- -- -- -- --
Total Liabilities $3.5B $7.5B $10.5B $12.9B $13.9B
 
Common Stock $410.1K $453.7K $423.5K $511K --
Other Common Equity Adj -$10M -$43.3M $150.2M $61.1M --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $718.4M $11.9M $32.1M $26.7M $13.4M
Total Equity $4.9B $5.5B $3.5B $3.6B $830.7M
 
Total Liabilities and Equity $8.4B $13B $14B $16.6B $14.7B
Cash and Short Terms $6.5B $8.2B $5.7B $7B $4.6B
Total Debt $1.2B $2.7B $4.2B $5.4B $2.8B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -$1.6B -$768.6M -$622.1M -$2.1B -$2.9B
Depreciation & Amoritzation $220.2M $224M $364.3M $594.6M $693.8M
Stock-Based Compensation $48.3M $27.1M $156.5M $341.8M $334.9M
Change in Accounts Receivable -$97.3M $17.2M -$489.7M -$317.9M $17.5M
Change in Inventories $82.4M -$28.7M -$153.4M -$931.6M $409.3M
Cash From Operations -$1.3B $282.7M $304.6M -$575.6M -$195.3M
 
Capital Expenditures $247.1M $163.4M $631.7M $1B $2B
Cash Acquisitions $6.5M -$36.3M -$91.8M $1.1M -$59.6M
Cash From Investing $489.6M -$734.8M -$6.2B $1.5B -$1.5B
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $825.1M $720.3M $2.4B $1B $2.3B
Long-Term Debt Repaid -$384.4M -$187.4M -$381.8M -$1.3B -$1.3B
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- $422.8M -$1.2B -$5.3M -$35.3K
Cash From Financing $448.1M $6B $2.8B -$240.6M $3.9B
 
Beginning Cash (CF) $466.8M $143.4M $6B $2.7B $3.3B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$325M $5.5B -$3B $729.9M $2.2B
Ending Cash (CF) $143.3M $5.6B $2.8B $3.4B $5.5B
 
Levered Free Cash Flow -$1.5B $119.3M -$327.2M -$1.6B -$2.2B
Period Ending 2019-06-30 2020-06-30 2021-06-30 2022-06-30 2023-06-30
Net Income to Stockholders -- -- -- -$686.8M -$1.5B
Depreciation & Amoritzation -- -- -- $244.6M $291M
Stock-Based Compensation -- -- -- $145.8M $171.1M
Change in Accounts Receivable -- -- -- -$55.7M -$92.8M
Change in Inventories -- -- -- -$197.8M -$27.7M
Cash From Operations -- -- -- -$204M -$1.7B
 
Capital Expenditures -- -- -- $523.9M $718.9M
Cash Acquisitions -- -- -- -$14.5M -$24.3M
Cash From Investing -- -- -- $1.3B $316.3M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- $924.1M $885.2M
Long-Term Debt Repaid -- -- -- -$510.1M -$594.6M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -$3.8M --
Cash From Financing -- -- -- $415.2M $292.9M
 
Beginning Cash (CF) -- -- -- $2.8B $3.3B
Foreign Exchange Rate Adjustment -- -- -- $9.2M $20.2M
Additions / Reductions -- -- -- $1.5B -$1B
Ending Cash (CF) -- -- -- $4.3B $2.3B
 
Levered Free Cash Flow -- -- -- -$727.9M -$2.4B
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation $40.2M $18.3M $94.7M $145.8M $171.1M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures $211.8M $137.5M $369.8M $523.9M $718.9M
Cash Acquisitions -$2.4M -$37.2M -$45.4M -$14.5M -$24.3M
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2021-04-01 2022-04-01 2023-04-01 2024-04-01
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Could IBIT Go?
How High Could IBIT Go?

Recently, a surprising number of billionaire hedge fund managers have…

Is Raymond James Stock a Buy, Sell or Hold?
Is Raymond James Stock a Buy, Sell or Hold?

Raymond James Financial (NYSE:RJF) is one of America’s large financial…

Is JHX Stock a Buy Sell or Hold?
Is JHX Stock a Buy Sell or Hold?

James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…

Stock Ideas

Buy
56
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
41
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 37x

Alerts

Buy
78
AJINY alert for Apr 1

Ajinomoto [AJINY] is down 2.15% over the past day.

Sell
40
RGC alert for Mar 31

Regencell Bioscience Holdings [RGC] is up 26.1% over the past day.

Buy
62
AGX alert for Apr 1

Argan [AGX] is down 4.98% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock